Centessa Pharmaceuticals (CNTA) said Thursday the board has appointed Mario Alberto Accardi, president and founder of its Orexin program, as chief executive officer, effective Jan. 1.
Accardi will succeed Saurabh Saha, who will step down and be appointed the CEO's adviser, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments